Correlation Between IShares Genomics and Principal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Genomics and Principal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and Principal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Genomics Immunology and Principal, you can compare the effects of market volatilities on IShares Genomics and Principal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of Principal. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and Principal.

Diversification Opportunities for IShares Genomics and Principal

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between IShares and Principal is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and Principal in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Principal and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with Principal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Principal has no effect on the direction of IShares Genomics i.e., IShares Genomics and Principal go up and down completely randomly.

Pair Corralation between IShares Genomics and Principal

Given the investment horizon of 90 days iShares Genomics Immunology is expected to under-perform the Principal. But the etf apears to be less risky and, when comparing its historical volatility, iShares Genomics Immunology is 1.08 times less risky than Principal. The etf trades about 0.0 of its potential returns per unit of risk. The Principal is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  3,294  in Principal on August 30, 2024 and sell it today you would earn a total of  655.00  from holding Principal or generate 19.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy83.64%
ValuesDaily Returns

iShares Genomics Immunology  vs.  Principal

 Performance 
       Timeline  
iShares Genomics Imm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Genomics Immunology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, IShares Genomics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Principal 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Principal has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Principal is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

IShares Genomics and Principal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Genomics and Principal

The main advantage of trading using opposite IShares Genomics and Principal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, Principal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Principal will offset losses from the drop in Principal's long position.
The idea behind iShares Genomics Immunology and Principal pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites